These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16564009)

  • 61. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.
    Abrami L; Leppla SH; van der Goot FG
    J Cell Biol; 2006 Jan; 172(2):309-20. PubMed ID: 16401723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Calpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.
    Jeong SY; Martchenko M; Cohen SN
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):E4007-15. PubMed ID: 24085852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
    Mamillapalli S; Miyagi M; Bann JG
    Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Whole-cell voltage clamp measurements of anthrax toxin pore current.
    Wolfe JT; Krantz BA; Rainey GJ; Young JA; Collier RJ
    J Biol Chem; 2005 Nov; 280(47):39417-22. PubMed ID: 16183642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Small molecule inhibitors of anthrax toxin-induced cytotoxicity targeted against protective antigen.
    Rubert Pérez C; López-Pérez D; Chmielewski J; Lipton M
    Chem Biol Drug Des; 2012 Mar; 79(3):260-9. PubMed ID: 22146079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
    Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human genetic variation altering anthrax toxin sensitivity.
    Martchenko M; Candille SI; Tang H; Cohen SN
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2972-7. PubMed ID: 22315420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
    Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
    Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.
    Sun J; Jacquez P
    Toxins (Basel); 2016 Jan; 8(2):34. PubMed ID: 26805886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Toxicity of anthrax toxin is influenced by receptor expression.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Sep; 15(9):1330-6. PubMed ID: 18596206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytoskeleton as an emerging target of anthrax toxins.
    Trescos Y; Tournier JN
    Toxins (Basel); 2012 Feb; 4(2):83-97. PubMed ID: 22474568
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
    Lee SC; Yoon MY
    Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8.
    Friebe S; Deuquet J; van der Goot FG
    PLoS One; 2015; 10(3):e0119864. PubMed ID: 25781883
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
    Jia Z; Ackroyd C; Han T; Agrawal V; Liu Y; Christensen K; Dominy B
    J Comput Chem; 2017 Jun; 38(15):1183-1190. PubMed ID: 28437008
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton.
    Werner E; Kowalczyk AP; Faundez V
    J Biol Chem; 2006 Aug; 281(32):23227-36. PubMed ID: 16762926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microbiology. Translocation of anthrax toxin: lord of the rings.
    von Heijne G
    Science; 2005 Jul; 309(5735):709-10. PubMed ID: 16051774
    [No Abstract]   [Full Text] [Related]  

  • 79. Designing a polyvalent inhibitor of anthrax toxin.
    Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ
    Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.
    Garlick KM; Batty S; Mogridge J
    Biochemistry; 2012 Feb; 51(6):1249-56. PubMed ID: 22303962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.